These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Benign oral vascular lesions treated by sclerotherapy with ethanolamine oleate: A retrospective study of 43 patients. Fernandes DT; Elias RA; Santos-Silva AR; Vargas PA; Lopes MA Med Oral Patol Oral Cir Bucal; 2018 Mar; 23(2):e180-e187. PubMed ID: 29476682 [TBL] [Abstract][Full Text] [Related]
5. Venous malformation of the tongue in a child treated by sclerotherapy with ethanolamine oleate: a case report. Nishikawa M; Sakamoto K; Hidaka M; Yamashita A; Yamamoto G J Pediatr Surg; 2006 Mar; 41(3):599-600. PubMed ID: 16516646 [TBL] [Abstract][Full Text] [Related]
6. Comparative effects of 5% ethanolamine oleate versus 5% ethanolamine oleate plus 1% polidocanol for sclerosing esophageal varices. Kitano S; Wada H; Tanoue K; Hashizume M; Koyanagi N; Sugimachi K Hepatogastroenterology; 1992 Dec; 39(6):546-8. PubMed ID: 1483669 [TBL] [Abstract][Full Text] [Related]
7. Reactive vascular lesions treated using ethanolamine oleate sclerotherapy. Hong SK; Lee HJ; Seo JK; Lee D; Hwang SW; Sung HS Dermatol Surg; 2010 Jul; 36(7):1148-52. PubMed ID: 20533938 [TBL] [Abstract][Full Text] [Related]
8. Ethanolamine oleate sclerotherapy combined with transarterial embolization using n-butyl cyanoacrylate for extracranial arteriovenous malformations. Kitagawa A; Izumi Y; Hagihara M; Kamei S; Ikeda S; Katsuda E; Kimura J; Ota T; Ishiguchi T Cardiovasc Intervent Radiol; 2014 Apr; 37(2):371-80. PubMed ID: 23737022 [TBL] [Abstract][Full Text] [Related]
9. Percutaneous sclerotherapy with ethanolamine oleate for venous malformations of the head and neck. Alexander MD; McTaggart RA; Choudhri OA; Marcellus ML; Do HM J Neurointerv Surg; 2014 Nov; 6(9):695-8. PubMed ID: 24235099 [TBL] [Abstract][Full Text] [Related]
10. Percutaneous sclerotherapy using a 4 F pigtail catheter and 40 milliliters of 5% ethanolamine oleate for symptomatic large hepatic cysts. Miyayama S; Yamashiro M; Ikeda R; Matsumoto J; Ogawa N; Notsumata K Diagn Interv Radiol; 2022 Mar; 28(2):149-155. PubMed ID: 35548899 [TBL] [Abstract][Full Text] [Related]
11. Ethanolamine oleate sclerotherapy versus simple cyst aspiration in the management of orbitopalpebral cyst associated with congenital microphthalmos. Naik MN; Honavar SG; Murthy RK; Raizada K; Thomas R Ophthalmic Plast Reconstr Surg; 2007; 23(4):307-11. PubMed ID: 17667104 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of Ethanolamine Oleate Sclerotherapy in Treatment of Peripheral Giant Cell Granuloma. Said Ahmed W J Oral Maxillofac Surg; 2016 Nov; 74(11):2200-2206. PubMed ID: 27235183 [TBL] [Abstract][Full Text] [Related]
13. Sclerotherapy for simple cysts with use of ethanolamine oleate: preliminary experience. Yamamoto K; Sakaguchi H; Anai H; Tanaka T; Morimoto K; Kichikawa K; Uchida H Cardiovasc Intervent Radiol; 2005; 28(6):751-5. PubMed ID: 16132390 [TBL] [Abstract][Full Text] [Related]
14. Percutaneous sclerotherapy with ethanolamine oleate for lymphatic malformations of the head and neck. Alexander MD; McTaggart RA; Choudhri OA; Marcellus ML; Do HM J Neurointerv Surg; 2014 Nov; 6(9):691-4. PubMed ID: 24153336 [TBL] [Abstract][Full Text] [Related]
15. Risk Factors for Macroscopic Haemoglobinuria After Sclerotherapy Using Ethanolamine Oleate for Venous Malformations. Fujiki M; Ozaki M; Kurachi I; Iwashina Y; Takushima A Eur J Vasc Endovasc Surg; 2019 Jul; 58(1):105-111. PubMed ID: 31133447 [TBL] [Abstract][Full Text] [Related]
16. High-flow arteriovenous malformation of the lower extremity: ethanolamine oleate sclerotherapy. Hyodoh H; Fujita A; Hyodoh K; Furuse M; Kamisawa O; Hareyama M Cardiovasc Intervent Radiol; 2001; 24(5):348-51. PubMed ID: 11815844 [TBL] [Abstract][Full Text] [Related]
17. Effects of blood flow control on clinical outcomes after ethanolamine oleate sclerotherapy for vascular malformations. Hyodoh H; Akiba H; Hyodoh K; Ezoe K; Yotsuyanagi T; Hareyama M Jpn J Radiol; 2009 Oct; 27(8):297-302. PubMed ID: 19856224 [TBL] [Abstract][Full Text] [Related]
18. Prospective randomized efficacy of ultrasound-guided foam sclerotherapy compared with ultrasound-guided liquid sclerotherapy in the treatment of symptomatic venous malformations. Yamaki T; Nozaki M; Sakurai H; Takeuchi M; Soejima K; Kono T J Vasc Surg; 2008 Mar; 47(3):578-84. PubMed ID: 18295109 [TBL] [Abstract][Full Text] [Related]
19. Monoethanolamine oleate sclerotherapy for the treatment of intraoral vascular anomalies: retrospective study and suggestion for a clinical guideline. Tolentino ES; Faria LO; Vargas RM; Camarini C; Santin GC; Chicarelli da Silva M Br J Oral Maxillofac Surg; 2020 May; 58(4):416-420. PubMed ID: 32057469 [TBL] [Abstract][Full Text] [Related]
20. Comparative effects of 5% ethanolamine oleate versus 5% sodium morrhuate for sclerotherapy of oesophageal varices. Kitano S; Wada H; Yamaga H; Hashizume M; Koyanagi N; Iwanaga T; Iso Y; Sugimachi K J Gastroenterol Hepatol; 1991; 6(5):476-80. PubMed ID: 1932669 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]